raloxifene hydrochloride has been researched along with Kidney Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Y; Ma, Y; Wang, X; Ye, B; Zheng, Y | 1 |
| Folse, DS; Liehr, JG; Roy, D | 1 |
2 other study(ies) available for raloxifene hydrochloride and Kidney Neoplasms
| Article | Year |
|---|---|
Raloxifene, identified as a novel LSD1 inhibitor, suppresses the migration of renal cell carcinoma.
Topics: Antineoplastic Agents; Binding Sites; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Evaluation, Preclinical; Enzyme Inhibitors; Flavin-Adenine Dinucleotide; Histone Demethylases; Humans; Kidney Neoplasms; Molecular Docking Simulation; Raloxifene Hydrochloride | 2021 |
Lack of effectiveness of antiestrogens RU 39,411 or keoxifene in the prevention of estrogen-induced tumors in Syrian hamsters.
Topics: Animals; Cricetinae; Estradiol; Estrogen Antagonists; Kidney Neoplasms; Liver Neoplasms; Male; Mesocricetus; Piperidines; Raloxifene Hydrochloride; Testicular Neoplasms | 1992 |